| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/09/2002 | US6369074 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | US6369068 Amino substituted pyrimidine containing compounds |
| 04/09/2002 | US6369061 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino) -3(2h)-pyridazinone |
| 04/09/2002 | US6369060 Central nervous system disorders such as anxiety; 5-methyl-6-trifluoromethyl-1-(6-(2-methylpyridin-3-yloxy)-pyridin-3-yl carbamoyl)indoline and 5-methyl-1-(6-(2-methylpyridin-3-yloxy) -pyridazin-3-ylcarbamoyl)-6-trifluoromethylindoline |
| 04/09/2002 | US6369057 Quinoxalines, processes for their preparation and their use |
| 04/09/2002 | US6369053 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 04/09/2002 | US6369002 Hetero is pyrimidine or pyridazine; 1-(3-fluoro-5-chloro pyridin-2-yl)-3-methyl-4-trifluoromethylpyrimidin-2,6-dione |
| 04/09/2002 | US6368520 Synergistic stabilizer mixture |
| 04/09/2002 | CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 04/09/2002 | CA2215732C Quinazoline derivatives |
| 04/09/2002 | CA2095338C Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents |
| 04/09/2002 | CA2048842C Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents |
| 04/04/2002 | WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026731A2 Quaternary amidino based inhibitors of factor xa |
| 04/04/2002 | WO2002026720A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026718A2 Bicyclic pyrimidin-4-one based inhibitors of factor xa |
| 04/04/2002 | WO2002026714A1 Spiro compounds |
| 04/04/2002 | WO2002026708A1 Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient |
| 04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
| 04/04/2002 | WO2002008195A8 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 04/04/2002 | WO2002004421A3 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
| 04/04/2002 | WO2002002521A3 Aroyl aminoacyl pyrrole compounds and their pharmaceutical use |
| 04/04/2002 | WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | WO2001087376A8 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/04/2002 | WO2001087263A3 Delivery systems for treatment of vascular disease |
| 04/04/2002 | WO2001081308A3 Aminopiperidines for use as glyt-1 inhibitors |
| 04/04/2002 | WO2001074815A3 Phenyl-substituted imidazopyridines |
| 04/04/2002 | WO2001074810A3 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
| 04/04/2002 | WO2001074773A3 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 04/04/2002 | WO2001066098A3 Therapeutic uses of ppar mediators |
| 04/04/2002 | WO2001064643A3 Benzamides and related inhibitors of factor xa |
| 04/04/2002 | WO2001047898A3 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 04/04/2002 | WO2001047507A3 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 04/04/2002 | US20020040148 Diphenyl heterocyclic thioamide derivatives |
| 04/04/2002 | US20020040147 Novel catechols as antimicrobial agents |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040144 For therapy of thrombotic disease, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury |
| 04/04/2002 | US20020040140 Crystalline therapeutic agent |
| 04/04/2002 | US20020040136 Vitronectin receptor antagonist |
| 04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 04/04/2002 | US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example |
| 04/04/2002 | US20020040028 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
| 04/04/2002 | US20020040026 Phenyloxy-and phenylthiosubstituted pyrimidines and triazines and derivatives useful for treating anxiety, depression, effective disorders, post-traumatic stress disorders etc. |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020040016 Derivatives of azetidine and pyrrolidine |
| 04/04/2002 | US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir |
| 04/04/2002 | US20020039598 Stabilized pharmaceutical composition and its production |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/04/2002 | CA2422873A1 Piperazin-2-one amides as inhibitors of factor xa |
| 04/03/2002 | EP1193266A1 Quinolinecarboxylic acid derivative or salts thereof |
| 04/03/2002 | EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides |
| 04/03/2002 | EP1193259A1 Dihydropyrimidine derivatives |
| 04/03/2002 | EP1192189A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 04/03/2002 | EP1192139A1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192131A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 04/03/2002 | EP1192129A2 Pharmaceutical compounds |
| 04/03/2002 | EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1158980A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1156807A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1140087A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
| 04/03/2002 | EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP0865281B1 Naphthyl-substituted benzimidazole derivatives as anticoagulants |
| 04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 04/02/2002 | US6365621 Remedies or preventives for intractable epilepsy |
| 04/02/2002 | US6365603 Aromatic compounds and pharmaceutical compositions containing them |
| 04/02/2002 | US6365602 For therapy of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions |
| 04/02/2002 | US6365600 For therapy of condition associated with smooth muscle cell proliferation in a warm-blooded animal which comprises administering imidazol-5-yl-methyl-2-quinolinone derivatives |
| 04/02/2002 | US6365599 For therapy of benign prostatic hyperplasia |
| 04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365584 For prophylaxis and therapy of inflammatory and/or allergic diseases, lung fibrosis, fibrosing alveolitis and scarring, collagenoses such as lupus erythematodes and sclerodermia as well as arteriosclerosis, psoriasis and neoplasm |
| 04/02/2002 | US6365583 Methods to enhance white blood cell count |
| 04/02/2002 | US6365552 Substituted 3-phenylpyrazoles |
| 04/02/2002 | US6365184 Multiple unit tableted dosage forms containing acid susceptible proton pump inhibitor in combination with one or more nsaids and wherein at least proton pump inhibitor is protected by enteric coated layer |
| 04/02/2002 | CA2253906C Process for preparation of pyrimidine derivatives |
| 04/02/2002 | CA2223574C Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein b (apo b) secretion |
| 04/02/2002 | CA2178130C Method of producing 2-naphthamide derivative, and compounds for producing 2-naphthamide derivative |
| 04/02/2002 | CA2099868C Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 04/02/2002 | CA2097928C Uracil derivatives |
| 03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
| 03/28/2002 | WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 03/28/2002 | WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024684A1 Quinoline derivatives as antibacterials |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024680A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024667A1 4-amino-quinazolines |
| 03/28/2002 | WO2002024665A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024661A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |